Transition from intravenous to enteral ketamine for treatment of nonconvulsive status epilepticus

BACKGROUND: Nonconvulsive status epilepticus (NCSE) is a diagnosis that is often challenging and one that may progress to refractory NCSE. Ketamine is a noncompetitive N-methyl-d-aspartate antagonist that increasingly has been used to treat refractory status epilepticus. Current Neurocritical Care S...

Descripción completa

Detalles Bibliográficos
Autores principales: Pizzi, Michael A., Kamireddi, Prasuna, Tatum, William O., Shih, Jerry J., Jackson, Daniel A., Freeman, William D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549373/
https://www.ncbi.nlm.nih.gov/pubmed/28808577
http://dx.doi.org/10.1186/s40560-017-0248-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549373/
https://www.ncbi.nlm.nih.gov/pubmed/28808577
http://dx.doi.org/10.1186/s40560-017-0248-6

Ejemplares similares